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Abstract
Eczema, or atopic dermatitis, is a complex and chronic condition that affects
approximately 10% of children throughout the United States (Brown et al., 2018). The
American Academy of Allergy Asthma & Immunology (AAAAI) (2017) estimates the
average cost of eczema management for each patient is approximately $3,302 per year.
The complex nature of atopic dermatitis indicates a need for individualized treatment
plans. Research has shown that standardized patient teaching, written education
materials, and Eczema Action Plans (EAP) reinforce patient teaching, parental
understanding, and improve quality of life. This evidence-based practice (EBP) project
introduces the use of a written Eczema Action Plan, using the template created by the
American Academy of Dermatology (AAD), for patients less than 18 years of age at
multiple private allergy clinics in California and Washington. The EAP provides written
instruction for how to cleanse and moisturize skin when symptoms are controlled and
during a flare, what medications should be used during a mild and moderate flare, and
what symptoms should prompt the patient to follow up with their allergist. The
implemented clinical intervention included providing an individualized EAP, in addition
to standardized written education materials about eczema and its treatment compiled into
one handout from the National Institute of Health (NIH) and the AAAAI to the parent or
caregiver of the pediatric patient. Patient outcomes were measured using the University
of Nottingham’s validated Patient Oriented Eczema Measure (POEM) form and parental
outcomes were measured using Parental Self-Efficacy Care Index (PAESCI) survey at
the introduction of the EAP and again at 6-9-weeks post-intervention. Of the 24
participants enrolled, 20 completed the study. Patient ages ranged from 9 months to 17
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years. PAESCI scores increased from an average of 47/70 pre-intervention to 60.9/70
post-EAP use, indicating increased caregiver self-efficacy. POEM scores decreased from
an average of 8.65/28 pre-EAP to 4.1/28 post-EAP, indicating a reduction in eczema
severity. At the time of receiving the EAP, parents had an average understanding of
8.9/10. This increased to an average understanding of a 9.65/10 after using the EAP for 69 weeks, indicating increased understanding after use. Benefits of EAPs along with
written education materials include reduction of patient costs on office visits and
medications due to flares, improved medication adherence, improved patient and
caregiver understanding, and improved patient quality of life. Use of an EAP within an
allergy clinic can also allow for better continuity of care between the patient’s primary
care providers and their allergists.
Keywords: eczema action plan, pediatric atopic dermatitis, allergy, caregiver selfefficacy, POEM, PASECI
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Managing Pediatric Atopic Dermatitis in the Allergy Clinic: Use of an Eczema Action
Plan to Improve Caregiver Understanding and Self-Efficacy
Background and Evidence for Problem
Eczema, or atopic dermatitis, is a complex and chronic condition that affects
approximately 10% of children throughout the United States (Brown et al., 2018). This is
a dynamic, multifactorial condition with periods of acute exacerbations that can vary in
severity. The nature of atopic dermatitis requires a treatment plan that is effective in
keeping the symptoms at bay and one that can manage acute exacerbations to prevent
complications such as infection (Brown et al., 2018). It is recommended by the American
Academy of Dermatology (AAD) that atopic dermatitis treatment plans involve skin care
regimens, methods for control of itching and inflammation, as well as management of
allergic triggers and infection (Brown et al., 2018). There is a high correlation between
eczema and other atopic conditions including food and environmental allergies, so it is
common for pediatric allergists to manage all atopic conditions presented by the patient.
At this time, there is no standardization for treatment of pediatric eczema in the United
States, which can lead to inconsistent management of care from the provider and the
child’s parent or caregiver.
The American Academy of Allergy, Asthma & Immunology (AAAAI) (2017)
estimates the average cost of eczema management for each patient is approximately
$3,302 per year. These costs can be attributed to visits with a provider in primary care,
allergy, or dermatology, eczema-friendly cleansing and skincare products, and
prescription medications (AAAAI, 2017). In addition to the high cost of care, the burden
of atopic dermatitis has also been found to negatively impact a person’s quality of life.

ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN

6

On average, patients experience a flare for 100 days out of the year (Sauder et al., 2016).
Parents of children with eczema often feel unsupported by their providers in treatment of
their child’s eczema and frequently feel that they are not provided with adequate
information to manage the condition at home (Powell et al., 2018). Uncontrolled eczema
symptoms of itching, bleeding, pain, and sleep disturbance can lead to limitations of
physical activity, social function, and can adversely affect a child’s emotional state
(Drucker et al., 2017). It is crucial for providers to create a customized and
comprehensive treatment plan for a child with atopic dermatitis to achieve a reduction in
flares. It is equally as important for those caring for a child with atopic dermatitis to have
an adequate understanding of the treatment plan to effectively manage eczema symptoms
to mitigate the damaging effect this chronic condition can have on a child’s quality of
life.
Proposed Evidence-Based Solutions
A literature review was conducted using key words including eczema action plan,
eczema management, atopic dermatitis, atopic dermatitis management, and eczema
patient education. CINAHL, PubMed, JSTOR, Cochrane, and Ovid databases were
searched. 27 articles were found to be pertinent and reviewed. 17 articles were utilized
for the Evidence-Based Practice (EBP) project. Evidence-based solutions proposed by the
reviewed articles included use of standardized patient education, written education
materials, and written action plans.
Standardized Education Materials
Standardized education materials for all pediatric patients with atopic dermatitis
within a specified clinical setting were shown to be effective for improving quality of life
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and caregiver understanding across several studies. A randomized controlled trial of 134
parents of children with moderate to severe atopic dermatitis measured the change in
severity of eczema symptoms using the Scoring Atopic Dermatitis (SCORAD) index and
the quality of family life using the Family Dermatology Life Quality Index (FDLQI) after
the implementation of a structured short-term parent education program (Pustisek et al.,
2016). The education program consisted of written materials that included a
corticosteroid use diary and an educational booklet on eczema (Pustisek et al., 2016). The
participants also received a lecture that included information presented by dermatologists,
psychologists, a dietician and was followed by nurse-led education (Pustisek et al., 2016).
The parents in the intervention group reported a significant improvement in the qualityof-life index (Pustisek et al., 2016). While there was no significant improvement in the
severity of symptoms for the intervention group, it was noted that the control group
sought out additional information on eczema to educate themselves on their child’s
condition (Pustisek et al., 2016).
A randomized controlled trial of 542 pediatric patients with moderate to severe
atopic dermatitis also measured the change in disease severity using the SCORAD index
as well as the quality of life with the Children’s Dermatology Life Quality index
(IDQOL) pre- and post-intervention of four once-weekly group education sessions (Liang
et al., 2018). The intervention group showed a significant improvement in eczema
severity and understanding of emollient use when compared to the control group (Liang
et al., 2018). Additionally, a systematic review of 10 randomized controlled trials
reviewing psychological and educational interventions for atopic dermatitis in children
revealed an overall increase in quality of life and decrease in symptoms after the
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implementation of nurse-led, multi-disciplinary, or medically led education focused on
the child’s parent (Ersser et al., 2017). These studies reveal that structured eczema
education materials can help to ensure patients receive comprehensive eczema education
needed to adequately care for the condition outside of the office.
Written Education Materials and Eczema Action Plans
Research has shown that another potential evidence-based solution for the deficit
in pediatric eczema education is the use of written education materials and more
specifically, eczema action plans. A meta-analysis of 287 eczema studies was conducted
to provide guidelines for successful treatment of atopic dermatitis (Sidbury et al., 2014).
The meta-analysis concluded that written education materials were found to reinforce
teaching and recommended their use to prevent and manage disease flares (Sidbury et al.,
2014). A randomized controlled trial of 211 caregivers of children with eczema
concluded that providers who utilized an eczema care plan documented more
comprehensive eczema care than the control group providers (Rea et al., 2018b). Better
documentation of a care plan can improve continuity of care, patient understanding, and
patient outcomes (Rea et al., 2018b). Rea et al. (2018a) also reported that in a crosssectional analysis of 224 pediatric patients with a diagnosis of eczema, a greater
understanding of a child’s individualized eczema plan was associated with a higher
quality of life. These conclusions were mirrored in a meta-analysis of 388 articles
exploring the use of written action plans (WAP) in management of children with atopic
dermatitis (Chilsom et al., 2008). Written action plans been proven to be a useful tool in
managing other chronic pediatric atopic conditions such as asthma and were proposed to
be an ideal choice for management of atopic dermatitis (Chilsom et al., 2008). The goal
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of a written action plan is to provide parents with a step-approach guide to manage their
child’s chronic condition (Chilsom et al., 2008). The findings concluded the use of WAPs
in the care of children with atopic dermatitis has substantial potential for improving both
adherence and outcomes (Chilsom et al., 2008).
A randomized controlled trial of 37 pediatric patients measured eczema symptom
severity and quality of life using a 10-question survey with a five-point Likert-type scale
before and after receiving education with a written Eczema Action Plan (EAP) (Brown et
al., 2018). Brown et al. (2018) reported a significant increase in understanding of atopic
dermatitis when compared to the control group. In addition, 90% of the patients who
received an EAP felt it was easy to understand and 100% reported they would like to
continue to use this tool (Brown et al., 2018). Similarly, Gilliam et al. (2016) reported
that in a randomized controlled trial of 88 pediatric patients, parents of children with
atopic dermatitis who received an EAP were more confident managing their child's atopic
dermatitis over time as compared with those who did not receive the EAP. Another
randomized controlled trial of 44 pediatric patients detected poor patient compliance with
eczema treatments and explored the use of an EAP to reduce Eczema Area and Severity
Index (EASI) (Sison et al., 2018). Results of the study showed that at four weeks postintervention, statistically significant reductions in EASI scores of the group who received
the EAP were present (Sison et al., 2018). Conclusions were drawn that an EAP is a
promising tool that can be utilized to improve severity of eczema symptoms and patient
compliance with eczema management (Sison et al., 2018).
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Gap Analysis
The pre-intervention data from eczema education studies show that patients are
sent home from office visits without adequate knowledge of atopic dermatitis
management resulting in increased eczema symptoms and decreased quality of life. This
is in part due to the complex and multifactorial nature of atopic dermatitis, as well as a
lack of an all-inclusive approach to managing eczema in children. The post-intervention
data from these same studies revealed that the use of structured patient education and
written education materials in the form of an individualized Eczema Action Plan were
effective in improving caregiver understanding, patient and family quality of life, and
reducing eczema symptom severity. In January 2020, the selected private allergy clinic
saw 43 patients with a diagnosis of L20.9 (Atopic Dermatitis) at their Fremont location,
27 of which were patients less than 18 years old. All of these patients received the
standard eczema education of verbal instructions presented to the child’s caregiver. This
patient analysis showed that there was an adequate sample size to justify implementation
of an evidence-based practice (EBP) intervention for eczema patient education to
incorporate individualized written education materials. The overarching goals of this
project were to reduce severity of patient’s atopic dermatitis symptoms and to increase
parental self-efficacy regarding at-home management of their child’s atopic dermatitis
through improved patient education methods.
Description of EBP Project
Project Overview
This EBP project was conducted at a private allergy practice utilizing the patient
population from five of their locations throughout the California and Washington areas.

ATOPIC DERMATITIS IN ALLERGY: USE OF AN ECZEMA ACTION PLAN

11

Four providers directly participated in the intervention, alongside the Doctor of Nursing
practice (DNP) candidate, five nurses, and three medical assistants. An office manager,
nursing supervisor, and the chief executive officer (CEO) were also involved for
administrative support of the project. Patients less than 18 year of age with a pre-existing
diagnosis of atopic dermatitis and an upcoming follow-up, allergy testing, or allergy
treatment appointments were identified by the DNP candidate as potential study
participants. New diagnoses of atopic dermatitis were identified by participating
providers during new patient and follow-up appointments as potential participants.
During the office visit, the DNP candidate or provider would introduce the patient
and caregiver to the study and determine potential participant interest. A packet of initial
patient forms was given for the patient’s parent to complete during the appointment after
interest in voluntary participation of the study was expressed. This packet consisted of a
participant demographic questionnaire, a Patient-Oriented Eczema Measurement (POEM)
form to obtain a baseline eczema severity score for the patient at the time of the visit, and
Parental Self-Efficacy with Eczema Care Index (PASECI) form to obtain baseline
parental comfort with caring for a child with eczema (see Appendix E). At the end of the
visit, the provider or DNP candidate presented the parent with a physical copy of the
completed Eczema Action Plan designed by the American Academy of Dermatology
(AAD), or an electronic copy, as shown in Appendix D, through the patient messaging
portal. The parent also received a handout of written eczema education materials, created
by the DNP student with input from the providers using materials from the National
Institute of Health (NIH) and American Academy of Allergy, Asthma, & Immunology
(AAAAI) (see Appendix E). After receiving the EAP, the parent was asked to complete a
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Caregiver’s Comprehension of Eczema Action Plan questionnaire (see Appendix E). The
parent was also given a post-intervention packet containing a POEM form, PASECI
form, and Caregiver’s Comprehension of Eczema Action Plan questionnaire with
instruction that the DNP candidate would follow up in six weeks. The parent was
informed that another copy of these forms would be sent via the email provided on the
demographics form and the clinic’s online patient portal. Average response time for
return of the post-intervention forms was 6.7 weeks. Pre- and post-intervention data were
collected on a spreadsheet in the clinic’s secure Google Drive. Completed Eczema Action
Plans were scanned into the patient’s charts by the nurses and medical assistants. The
EAPs would be visible to providers at all clinic locations to assist with continuity of care.
Measurements and Outcomes
This EBP project used three measures to evaluate project outcomes. The first
outcome to be measured was the change in eczema severity pre- and post- EAP use. This
outcome would be measured using the University of Nottingham’s widely accepted
Patient-Oriented Eczema Measure scale, which inquiries about patient symptoms over a
one-week period with the use of seven questions and a total potential score of 28. The
POEM scale was chosen due to provider familiarity within the allergy clinics. In the case
of this scale, a score of 28 indicates severe eczema, while a score of zero represents no
current symptoms. The next outcome to be measured was parental comfort with
managing their child’s eczema pre- and post- intervention. This outcome was to be
measured using the Parental Self-Efficacy with Eczema Care Index, a seven-question
survey using a 10-point Likert-scale, with a potential total score of 70. Ersser et al. (2015)
demonstrated that their 29-item PASECI scale had “face, content and construct validity
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and reliability,” (p.1483) with Cronbach’s Alpha values of 0.906, 0.874, 0.915 and 0.953
across the four domains assessed when tested in a 242-parent focus group. The sevenquestion survey tool for this project has a calculated Cronbach’s Alpha score of 0.96
indicating excellent internal consistency. A total score of 70 on the seven-question
PASECI survey indicates total self-efficacy with a child’s eczema management, while a
score of zero indicates a lack of self-efficacy. The last outcome measured was the degree
of parent or caregiver understanding of the presented EAP. This outcome was measured
using a one question 10-point Likert-scale survey with a total potential score of 10. The
maximum score of 10 indicated complete comprehension of the EAP, while a score of
zero indicated no understanding. Measurements on all three outcomes were to be taken at
the time of receiving the EAP, and six weeks post-EAP.
Anticipated Outcomes
Based on the reported findings from randomized controlled trials reviewed in the
literature search, there were several anticipated positive impacts of the EBP project. Short
term goals following the implementation of written education materials and an EAP for
pediatric patients with a diagnosis of atopic dermatitis at the allergy clinics would ideally
reduce eczema severity as indicated by a reduction in POEM scores and increase parental
understanding of the condition as indicated by an increase in PAESCI scores. The third
goal was for there to be an adequate parental understanding of the provided EAP. Other
anticipated benefits of the project that would not be directly measured included patient
improvement in health literacy regarding atopic dermatitis, better control of eczema
resulting in a decreased need for follow up visits due to eczema flares, and better
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continuity of care with provider use of a standardized and complete action plan and use
of eczema severity index scales to gauge success of treatment protocols.
PICOT Question
In allergy clinic patients less than 18 years of age with a diagnosis of atopic
dermatitis (eczema) (P), does implementing the use of written education materials to the
patient’s caregiver/parent in the form of an Eczema Action Plan in addition to verbal
teaching (I), compared to the standard verbal teaching (C), result in a decrease in severity
of patient reported eczema symptoms measured by the POEM form and increased
parental self-efficacy of at-home eczema management measured by the Parental SelfEfficacy Index (O) within 6-10 weeks (T)?
EBP Model
The Iowa Model was selected as the evidence-based practice (EBP) model for
implementing an Eczema Action Plan for pediatric patients with atopic dermatitis at an
allergy clinic. The identified evidence-based practice project involved implementing a
new eczema education process within an allergy clinic. Using the Evaluation Criteria for
the EBP Model chart provided by Gawlinski and Rutledge (2008), several EBP models
were compared for potential use. Upon comparison of the Iowa Model, Stetler Model,
ACE Star Model and Johns Hopkins Nursing Model, the Iowa Model scored the highest
against the six evaluation criteria. The Iowa Model was clear and concise, allowed quick
assimilation of concepts, was comprehensive throughout, easy to use in a clinical setting,
and applied well to the selected project (Gawlinski & Rutledge, 2008). The Iowa Model
has a strong emphasis on organizational process, and therefore is a good fit for guiding
this EBP project (Gawlinski & Rutledge, 2008).
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Project Process Plan
The EBP project was set into motion with a letter of support provided by the CEO
and Founder of the allergy practice on March 6, 2020. The letter of support allowed for
use of data from the clinic-site for an evidence-based class project and possible
presentations and publications. This was followed by a letter indicating University of San
Diego (USD) faculty approval on April 29, 2020. USD Institutional Review Board
approval of exempt status was obtained on May 8, 2020. The DNP candidate provided
staff training on proper implementation of the EBP project July 28, 2020 through July 31,
2020. Implementation of the use of written education materials and the EAP began on
August 27, 2020 along with data collection. Additional provider education presented by
the DNP candidate took place on September 22, 2020. A total of 24 patients from
California and Washington locations volunteered to participate in this EBP project. The
DNP candidate presented the opportunity to participate in the study to patients who met
the inclusion criteria. Willing providers at select clinic locations completed the EAP form
for enrolled patients. The DNP candidate followed up with the parent/caregiver in person,
by phone, email, or patient messaging system at the end of the initial appointment to
provide additional education as needed. At six weeks post intervention, participants were
contacted by means of email, telephone, text message, or patient messaging system to
complete post-EAP forms including the POEM, PAESCI and parental understanding of
the EAP forms. 20 of the 24 enrolled patients completed the post intervention survey.
Four patients were lost to follow-up for undetermined reasons. Data collection concluded
January 23, 2020. Data analysis took place January 23, 2021 through January 29, 2021.
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Results
A total of 10 female and 10 male patients between the ages of nine months and 17
years participated in the study, 75% of whom were of Asian and Southeast Asian descent
(see Figure 1). Breakdown of the number of patients in each age range can be found in
Table 1. 35% of participants had one other atopic condition, 35% had two other atopic
conditions, and 20% had asthma, hayfever, and food allergies as comorbid atopic
conditions (see Table 2). 70% of patients had a family history of one or more atopic
conditions. 19 of the 20 study participants had pre-existing diagnosis of atopic dermatitis
for more than one year (see Table 4), and only two of the participants had previously
used an EAP (see Table 5).
At the initial visit, POEM scores for the 20 participants averaged an 8.6/28,
indicating most patients had moderate eczema. Six to nine weeks post-EAP, average
POEM scores decreased to 4.1, indicating an improvement in eczema severity to mild
after the use of an EAP and written education materials (see Figure 2). The most common
eczema symptoms experienced for the 20 participants pre- and post-EAP were itchy skin
and rough skin (see Figure 4). A reduction in the average number of days of symptoms
was experienced across the patient population. PASECI average scores increased by 13.2
points, from 47.7/70 to 60.9/70, indicating an overall improvement in parental selfefficacy with caring for their child’s eczema (see Figure 3). Parents initially felt most
confident in their ability to apply moisturizer to their child with eczema. Parents noted an
increased self-efficacy across all patients in all areas of eczema management 6-9 weeks
post-EAP (see Figure 5), with comfort in managing infected skin having the most
significant improvement post-EAP. This shows the AAD EAP’s specific instructions to
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call the dermatologist with symptoms of infected skin such as skin weeping or oozing
pus, painful skin, severe itching, fever, or chills helped to increase parental comfort with
managing this complication. 85% of parents scored their understanding of the EAP at an
8/10 or better (see Table 6). After using the EAP for 6-9 weeks, the parent’s felt that they
understood the EAP even better as indicated by an increased average score of 9.65/10
from 8.9/10 (see Figure 6). This indicates that the chosen EAP format was easy to
understand and an effective tool for educating parents on caring for their child’s eczema.
Dissemination
Collected data and results from the EBP project were presented at a stakeholder
meeting which took place virtually via Google Drive Meeting on April 9, 2021 (see
Appendix C). Meeting attendees included the DNP candidate, the allergy clinic’s CEO
and founder, clinical manager, and the USD clinical faculty. A poster summary of the
project (see Appendix B) and the results were emailed out to the providers and charge
nurses at all the company’s clinic locations throughout California, Idaho, Oregon, and
Washington. The Eczema Action Plan form and eczema handouts were included in this
email and uploaded to the company’s Google Drive. The findings from this EBP project
were also presented to USD DNP candidates and their faculty advisors at the DNP
Presentation Day event on March 4, 2021. A poster presentation of this EBP project took
place at the Western Institute of Nursing (WIN) conference held virtually April 14-16,
2021 (see Appendix A).
Cost-Benefit Analysis
Current costs for the standard verbal education only for pediatric eczema patients
at the allergy clinic are $0. Total project costs for the implementation of the EAP and
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written eczema education materials for 20 study participants were approximately $528.
These costs included an estimated $480 for salary costs related to time needed for staff
training of providers, nursing staff, and medical assistants, and $48 for printing of the
patient forms. Potential financial benefits for the clinic with this intervention include
being able to bill for atopic dermatitis as a problem for the visit, and potentially increase
the total number of problems addressed at the visit to bill at a higher level, if appropriate.
The estimated average cost of eczema treatment per year is $3,302 per patient per year,
$1,060 of which are out of pocket costs (AAAAI, 2017 & Zink et al., 2019). A reduction
in severity of eczema symptoms due to increased caregiver understanding of the
condition and a clear treatment plan could help to reduce the number of unnecessary
eczema treatments and office visits due to flares and reduce the number of ineffective
over-the-counter products used. In a program size of 20 patients, for every dollar spent
there is an estimated $18.71 cost savings for the patients. In a program size of 20 patients,
there would be a 1771.21 % ROI.
Non-financial benefits of the project include implementation of a streamlined
process for managing eczema at the allergy clinics to allow for seamless transition of care
between providers at these locations. More comprehensive documentation with an
emphasis on patient education practices and ensuring patient understanding could
improve medication adherence and as a result improve patient morale and satisfaction.
Sustainability
The low costs associated with the startup and maintenance of the project make
this a promising EBP intervention to implement long-term at the allergy clinics. There is
evidence to support use of an Eczema Action Plan and written education materials as a
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facility guideline for managing atopic dermatitis in the pediatric allergy setting. It is
recommended for use of an EBP to be written in as a new guideline and staff training
should be performed to educate all providers and medical personnel on the guideline. A
charge nurse or provider should be appointed as a lead at each location to ensure proper
and consistent use of the education materials for the first six months the new guideline is
enforced. As patients become familiar with the EAP and receiving written materials, it
will become an expectation to receive these tools at each visit.
Implications for Clinical Practice
This study confirms that the use of an EAP, when followed, can improve parental
confidence in appropriately managing their child’s eczema and reduce the severity of
their child’s eczema symptoms. Utilization of an EAP in combination with written
education materials provides more comprehensive patient education which can improve
medication adherence, decrease symptom severity, save money on extra appointments
and treatment due to flares. Standardized patient education in the form of an EAP creates
better continuity of care and the results of this study support the recommendation of
writing this EBP intervention into clinic protocols for management of pediatric atopic
dermatitis. It is recommended that this project be expanded to the remaining clinic
locations within company, and in the future the clinic can also consider expanding these
education methods to adult patients.
Limitations
Several limitations arose throughout the duration of the EBP project, a majority of
which could be attributed to the COVID-19 Pandemic. Several staffing changes occurred
between the time the letter of support was obtained, the time of staff training, and again
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when project implementation took place as a result of the financial burden of the
pandemic. The DNP candidate was only able to enroll 24 participants, 20 of which
completed the post-intervention documents. The first challenge noted in recruiting
patients was that many of patients had their atopic dermatitis managed by a dermatologist
or the pediatrician, so an EAP from someone other than the prescribing provider did not
seem appropriate. In addition, the pandemic led to a decreased patient volume and most
appointments were moved to a telehealth format. Telehealth visits tend to be shorter than
physical office visits, and an increased difficulty was noted when it came obtaining
patient interest and buy-in through telehealth visits when compared to physical office
visits. The more hands-off nature of the telehealth visits and the extra steps involved for
the patient after their appointment of having to send and receive extra documents could
account for this. Another challenge with recruiting patients was that all written education
materials were only provided in English. 85% of the 20 participants spoke English as
their first language, while the remaining 15% selected Mandarin and Nepali and their first
languages. The final limitation noted for this EBP project was that there was no way to
account for the affect that the time of year, concurrent allergy treatments, or specific
allergies had on eczema severity as these data points could potentially lead to a different
interpretation of the patient outcomes.
Conclusion
The use of an individualized Eczema Action Plan along with standardized written
eczema education materials proved to be an effective intervention for reducing eczema
severity in patients less than 18 years of age in a private allergy clinic, as indicated by a
reduction in average POEM severity scores from moderate severity to mild severity 6-9
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weeks post implementation of the new education materials. These data points also
showed that there was adequate parental understanding of the Eczema Action Plan, which
contributed towards increased parental self-efficacy across seven different categories, as
indicated by an increased average PASECI score 6-9 weeks post intervention. Both shortterm goals for this project were met. The successful completion of the short-term goals in
addition to the low implementation costs, financial benefits of the project, and nonfinancial benefits of the project give support for the recommendation to keep this EBP
intervention as a new guideline for managing atopic dermatitis in the pediatric population
at all allergy clinics within the company.
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Tables
Table 1
Ages of Patients in the Study
Age
< 1 year
1-5 years
6-10 years
11-15 years
15-18 years

Incidence
2
8
5
3
2

Percentage
10%
40%
25%
15%
10%

Table 2
Comorbid Atopic Conditions
Condition
Asthma only
Hayfever only
Food Allergies only
Asthma & Hayfever only
Asthma & Food Allergies only
Hayfever & Food Allergies only
Asthma, Hayfever & Food Allergies
None

Incidence
0
0
7
0
1
6
4
2

Percentage
0%
0%
35%
0%
5%
30%
20%
10%

Table 3
Family History of Atopic Conditions
Condition
Asthma only
Hayfever only
Food Allergies only
Asthma & Hayfever only
Asthma & Food Allergies only
Hayfever & Food Allergies only
Asthma, Hayfever & Food Allergies
None

Incidence
1
5
1
3
0
1
3
6

Percentage
5%
25%
5%
15%
0%
5%
15%
30%
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Table 4
Duration of Eczema Diagnosis
Duration
< 6 months
6 -12 months
More than one year

Incidence
1
4
15

Percentage
5%
20%
75%

Incidence
2
18

Percentage
10%
90%

Table 5
Previous Use of Eczema Action Plan
Prior Use of EAP
Yes
No

Table 6
Caregiver Understanding of EAP at Initial Visit
Total Score (0-10)
5
6
7
8
9
10

Incidence
0
1
2
4
4
9

Percentage
0%
5%
10%
20%
20%
45%
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Figures
Figure 1

RACE OF STUDY PARTICIPANTS
Asian

Southeast Asian (Indian)

5%

White

Black

Other

Asian/White

5%

5%
10%

40%

35%

Note: Most patients included this study were of Asian and Southeast Asian
(Indian) descent.

Figure 2

Average POEM Scores Pre/Post EAP
TOTAL POEM SCORE (MAX 28)

10
9

8.7

8
7
6
5

4.1

4
3
2
1
0

POEM Pre-EAP

POEM Post-EAP

Note: POEM scores decreased by an average score of 4.1, indicating a reduction in
eczema severity 6-9 weeks post-EAP use.
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Figure 3

AVEREAGE TOTAL SCOERE (MAX 70)

Average PASECI Scores Pre/Post
EAP
70

60.9

60
50

47.7

40
30
20
10
0

PASECI Pre-EAP

PASECI Post-EAP

Note: PASECI average scores increased by 13.2 points, indicating an overall
improvement in parental self-efficacy with caring for their child’s eczema.
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Figure 4

2
0.4

0.75

1.10

0.05

0.5

0.20

0.02

1

0.05

0.90

1.5

0.6

2

1.45

1.7

2.5

2.25

AVERAGE SCORE (0-4)

3

2.55

POEM Score Breakdown Per Question

POEM Pre-EAP
POEM Post-EAP

0
Days itchy Disturbed
Skin
skin oozing
skin
skin flaking rough skin
Sleep
bleeding
cracked
SYMPTOM ASSESSED

Note: The most common eczema symptoms experienced were itchy skin and rough skin.
A reduction in the average number of days of symptoms was experienced across all
participants.
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Figure 5

PASECI Score Breakdown Per Question Pre/Post EAP

Average Score (Comfort level 0-10)

PASECI Pre-EAP
10
9
8
7
6
5
4
3
2
1
0

9.05

7.2

9.1

8.65

PASECI Post-EAP
8.7

8.45

8.4

8.55

7.9
7
6.5

Choose
Apply
Use Steroid Choose
Moisturizer Moisturizier
Cream Correct Med

6.9
6.05

Avoid
Irritants

Control
Symptoms

6.15

Manage
Infection

Note: Parents initially felt most confident in their self-efficacy with applying moisturizer
to their child with eczema and least confident in their self-efficacy with avoiding eczema
irritants. Parents noted an increased self-efficacy across the board in all areas of eczema
management 6-9 weeks post-EAP.
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Figure 6
Caregiver's Comprehension of Eczema Action Plan

AVERAGE TOTAL SCORE (0-10)

9.8

9.65

9.6
9.4
9.2
9

8.9

8.8
8.6
8.4

Initial Visit

After 6 weeks of use

Note: On average, parents scored 8.9/10 for their understanding of the Eczema Action
Plan after immediately receiving the EAP. After using the EAP for 6-9 weeks, the
parent’s felt that they understood the EAP even better as indicated by an average score of
9.65/10.
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Appendix A
Poster Abstract with Letter of Acceptance to Conference
Abstract
Managing Pediatric Atopic Dermatitis in the Allergy Clinic: Use of an Eczema
Action Plan
Eczema, or atopic dermatitis, is a complex and chronic condition that affects
approximately 10% of children throughout the United States (Brown et al., 2018). The
American Academy of Allergy Asthma & Immunology (AAAI) (2017) estimates the
average cost of eczema management for each patient is approximately $3,302 per year.
The complex nature of atopic dermatitis indicates a need for individualized treatment
plans. Research has shown that standardized patient teaching, written education
materials, and Eczema Action Plans (EAP) reinforce patient teaching, parental
understanding, and improve quality of life. This evidence-based practice project
introduces the use of a written EAP, using the template created by the American
Academy of Dermatology (AAD), for patients less than 18 years of age at multiple
allergy clinics in California and Washington. The implemented clinical intervention
included providing an individualized EAP, in addition to standardized written education
materials about eczema and its treatment compiled into one handout from the National
Institute of Health (NIH) and the AAAI to the parent or caregiver of the pediatric patient.
Patient outcomes were measured using the University of Nottingham’s validated Patient
Oriented Eczema Measure (POEM) form and parental outcomes were measured using
Parental Self-Efficacy Care Index (PAESCI) survey at the introduction of the EAP and
again at 6-8-weeks post-intervention. Results are pending. Benefits of EAPs along with

34
written education materials include reduction of patient costs on office visits and
medications due to flares, improved medication adherence, improved patient and
caregiver understanding, and improved patient quality of life. Use of an EAP within an
allergy clinic can also allow for better continuity of care between the patient’s primary
care providers and the allergists.

Keywords: eczema action plan, pediatric atopic dermatitis, allergy, caregiver selfefficacy, POEM, PASECI
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Appendix D
DNP Program Outcomes Exemplars
AACN DNP Essentials &
NONPF Competencies

USD DNP
Program
Objectives

Exemplars

2. Synthesize
● Developed a scientific
nursing and other
understanding of human biology
scientific and
and disease processes through an
ethical theories and
Advanced Pathophysiology
NONPF: Scientific
concepts to create
course (ANPC 520, Fall 2018)
Foundation Competencies a foundation for
● Explored the history of
advanced nursing
vaccinations, incidence and
The scientific foundation of
practice.
prevalence of disease and
nursing practice has expanded
relevant historical information
and includes a focus on both the
related to health care through an
natural and social sciences
Epidemiology course (DNPC
including human biology,
genomics, science of therapeutics,
625, Fall 2018)
psychosocial sciences, as well as
● Gained an understanding of how
the science of complex
to synthesize research related to
organizational structures. In
health care and utilize evidenceaddition, philosophical, ethical,
based practice through a
and historical issues inherent in
the development of science create
Methods of Translational
a context for the application of
Science course (DNPC 611, Fall
the natural and social sciences
2018)
● Developed a scientific
understanding of pharmacology
and best practice in prescribing
medications about multiple
conditions in a Pharmacology in
Health Management course
(ANPC 523, Spring 2019)
● Demonstrated an understanding
of reflective practice and
professional development in
advance practice nursing through
discussions, readings, and
practice with written narratives
(DNPC 610, Summer 2019)
● Applied knowledge of advanced
pathogenesis and clinical
genetics in the evaluation of
patients with multi-system
disease states through a mock
DNP Essential I: Scientific
Underpinnings for
Practice
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NP Essential I: Scientific
Underpinnings for
Practice
NONPF: Scientific
Foundation Competencies

2. Synthesize
genetic case conference
nursing and other
presentation and Evidence-Based
scientific and
Synthesis & Pathogenesis
ethical theories and
Presentation & Manuscript
concepts to create
(DNPC 622, Fall 2019)
a foundation for
● Gained knowledge of
advanced nursing
developmental and health
practice.
screening methods across the
lifespan and appropriate patient
interview techniques and applied
these concepts within the context
of a Primary Care Clinical
Setting (NPTC 602, Fall 2019).
● Gained an understanding of how
to appropriately assess all body
systems of patients throughout
the lifespan to gain subjective
and objective information
needed to create an assessment
and plan. Practiced application
of these skills through weekly
labs, OSCEs, and the primary
care clinical setting (APNC 521,
Fall 2019)
● Continued to build a foundation
of primary care theory through
lecture, OSCEs, and hands-on
application of common acute and
chronic conditions throughout
the lifespan for each body
system at a primary care clinical
site (NPTC 604, Spring 2020)
● Continued to build a foundation
of primary care theory through
lecture and OSCEs on pediatric,
neuro, OB/GYN, hematologic,
endocrine, metabolic,
pulmonary, and cardiac
conditions as well as topics such
as ethical principles to managing
patients with advanced stage
heart failure, maintaining
privacy during telehealth,
nutrition management (NPTC
605, Summer 2020)
● Continued to build a foundation
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NP Essential I: Scientific
Underpinnings for
Practice
NONPF: Scientific
Foundation Competencies

DNP Essential II:
Organizational & System
Leadership for Quality
Improvement & Systems
Thinking
NONPF: Leadership
Competencies/Health
Delivery System
Competencies
Advanced nursing practice
includes an organizational and
systems leadership component
that emphasizes practice, ongoing
improvement of health outcomes,
and ensuring patient safety.
Nurses should be prepared with
sophisticated expertise in
assessing organizations,
identifying system’s issues, and
facilitating organization wide
changes in practice delivery. This
also requires political skills,
systems thinking, and the business
and financial acumen needed for
the analysis of practice quality
and costs.

2. Synthesize
of primary care theory through
nursing and other
lecture and OSCEs on eye,
scientific and
orthopedic, cardiac, neurologic,
ethical theories and
women’s health, GI, male GU,
concepts to create
and dermatologic conditions
a foundation for
(NPTC 608, Summer 2020)
advanced nursing
● Continued to build on the
practice.
foundation for conditions
managed in primary care through
theory, OSCEs, and clinical
application of common complex
and/or unstable acute and
chronic health problems across
the lifespan (NPTC 609, Spring
2021)
5. Design,
implement, and
evaluate ethical
health care
delivery systems
and information
systems that meet
societal needs and
ensure
accountability for
quality outcomes.

● Built a foundation for tools and
processes involved in quality
improvement in health care and
strategic planning through a
Strategic Planning and Quality
Initiatives Course. Applied this
knowledge through an individual
project analyzing a case study
regarding overuse of antibiotics
(DNPC 626, Spring 2019).
● Built a foundation of awareness
of Health Policy and how to
become involved through a
Health Policy course (DNPC
658, Spring 2019). Within this
course submitted a policy
proposal to the ANA regarding
overuse of medical tests
● Worked towards improving
patient care using reflective
practice (DNPC 610, Summer
2019). Gaining the ability to
critically reflect on my own
actions and experiences has
allowed me to connect with my
patient and lead a team more
effectively.
● Developed a business plan for a
product/service to improve
current health care practices
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DNP Essential II:
Organizational & System
Leadership for Quality
Improvement & Systems
Thinking
NONPF: Leadership
Competencies/Health
Delivery System
Competencies

5. Design,
implement, and
evaluate ethical
health care
delivery systems
and information
systems that meet
societal needs and
ensure
accountability for
quality outcomes.

●

●

●

●

including evaluation of current
and similar product/services and
presented the idea to peers and
professors (DNPC 653, Summer
2019)
Created a sample evidence-based
practice project including
conducting a literature review
and critically evaluating the
evidence, writing a PICOT
question, researching
conferences available to present
the results to, and creating a
mock stakeholder presentation
(DNPC 686, Spring 2020)
Gained experience in ensuring
patient safety while caring for
patients with common conditions
in a primary care setting through
an understanding of red flag
symptoms for common
conditions, ethical principles,
and informed consent (NPTC
604, Spring 2020)
Continued to develop leadership
skills through review of ethical
principles, APRN scope of
practice, and standards and
guidelines for providing clinical
care (NPTC 605 & 608, Summer
2020)
Created and implemented an
evidence-based practice project
on use of an Eczema Action Plan
in allergy clinics. This included
conducting a literature review
and critically evaluating the
evidence, writing a PICOT
question, implementing the use
of an EAP for patients < 18,
creating a stakeholder
presentation, and presenting at
the WIN conference (DNPC
630, Spring 2020-Spring 2021)
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4. Incorporate
● Gained an understanding of how
research into
to synthesize research related to
practice through
health care and utilize evidencecritical appraisal of
based practice through a
existing evidence,
Methods of Translational
NONPF: Quality
evaluating practice
Science course. Applied this
Competencies/Practice
outcomes, and
knowledge through a term paper
Inquiry Competencies
developing
which discussed the analysis of
evidence-based
articles regarding food allergy
Scholarship and research are the practice guidelines.
testing and utilized evidencehallmarks of doctoral education.
based practice to suggest
Although basic research is viewed
implementation of early food
as the first and most essential
allergy detection in at-risk
form of scholarly activity, an
enlarged perspective of
children (DNPC 611, Fall 2018)
scholarship has emerged through
● Built a foundation for tools and
alternative paradigms that
processes involved in quality
involve more than discovery of
improvement in health care and
new knowledge. These paradigms
strategic planning through a
recognize: (1) the scholarship of
discovery and integration
Strategic Planning and Quality
“reflects the investigative and
Initiatives Course. Applied this
synthesizing traditions of
knowledge through an individual
academic life”; (2) scholars give
project analyzing a case study
meaning to isolated facts and
regarding evidence-based
make connections across
disciplines through the
changes to be made to reduce the
scholarship of integration; and
overuse of antibiotics (DNPC
(3) the scholar applies knowledge
626, Spring 2019).
to solve a problem via the
● Developed a business plan for a
scholarship of application that
food allergy kit after analyzing
involves the translation of
research into practice and
the current food allergy market
dissemination and integration of
and products to improve current
new knowledge.
food allergy practices including
evaluation of current and similar
products and presented the idea
to peers and professors (DNPC
653, Summer 2019)
● Researched, synthesized, and
presented Evidence-Based
guidelines and up-to-date
information on the pathogenesis
of selected conditions guide
peers in the evaluation of
patients with multi-system
disease states (DNPC 622, Fall
2019)
● Applied theoretical knowledge
of recommended routine
DNP Essential III: Clinical
Scholarship & Analytical
Methods for EvidenceBased Practice
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DNP Essential III: Clinical
Scholarship & Analytical
Methods for EvidenceBased Practice
NONPF: Quality
Competencies/Practice
Inquiry Competencies

4. Incorporate
screenings for adults and
research into
children and recommended
practice through
immunizations throughout the
critical appraisal of
lifespan through complete
existing evidence,
physical assessments performed
evaluating practice
at a primary care clinical site
outcomes, and
(NPTC 602, Fall 2019).
developing
● Gained theoretical knowledge of
evidence-based
how to properly assess all body
practice guidelines.
systems on patients of all ages
and demonstrated proper
technique through skills labs and
OSCEs. Also developed the
ability to critically think and
create a list of differential
diagnoses based on the objective
clinical findings (APNC 521,
Fall 2019).
● Went through the steps of
developing a mock EBP project
based on a literature review and
need for improvement within a
theoretical clinical site.
Synthesized the evidence to
apply the research into a
theoretical clinical site with an
EBP model (DNPC 686, Spring
2020).
● Utilized current guidelines
supported by research to
promote and perform routine
health screenings during
complete physical exams within
a primary care setting (NPTC
604, Spring 2020)
● Continued to integrate
knowledge of pathophysiology,
pharmacology, and assessment
skills to develop a list of
differential diagnoses and
understanding of primary care
conditions. Also applied these
concepts to perform OSCEs on
Women’s health, respiratory
conditions, and dermatologic
conditions (NPTC 605 & 608,
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DNP Essential III: Clinical
Scholarship & Analytical
Methods for EvidenceBased Practice
NONPF: Quality
Competencies/Practice
Inquiry Competencies

DNP Essential IV:
Information
Systems/Technology &
Patient Care Technology
for Improvement &
Transformation of Health
Care

4. Incorporate
Summer 2020) Also applied this
research into
knowledge to come up with a list
practice through
of meaningful differential
critical appraisal of
diagnoses within the laser &
existing evidence,
cosmetic dermatology clinical
evaluating practice
setting (NPTC 605 & 608, Fall
outcomes, and
2020)
developing
● Gained a theoretical knowledge
evidence-based
of practice guidelines for
practice guidelines.
common complex and/or
unstable acute and chronic health
problems including the PERC
rule, Ottawa Ankle and Knee
rules, Well’s Criteria, SF
Syncope, Canadian C-Spine,
NEXUS, New Orleans CT Rule,
Sgarbossa’s Criteria, PECARN
and more (NPTC 609, Spring
2021)
● Created and implemented an
evidence-based practice project
on use of an Eczema Action Plan
in allergy clinics. This included
conducting a literature review
and critically evaluating the
evidence, writing a PICOT
question, implementing the use
of an EAP for patients < 18,
creating a stakeholder
presentation, and presenting at
the WIN conference (DNPC
630, Spring 2020-Spring 2021)

7. Incorporate
ethical, regulatory,
and legal
guidelines in the
delivery of health
care and the
selection, use, and
evaluation of
NONPF:
information
Technology & Information systems and
Literacy Competencies
patient care
technology.

● Built a foundation regarding the
rules, regulations, and
application of healthcare
informatics through an
Introduction to Health Care
Information Management
course. Gained hands-on
experience utilizing Microsoft
Excel as a tool to be used within
the health-care system (HCIN
540, Spring 2019)
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DNP graduates are distinguished
by their abilities to use
information systems/technology to
support and improve patient care
and health care systems, and
provide leadership within health
care systems and/or academic
settings. Knowledge and skills
related to information
systems/technology and patient
care technology prepare the DNP
graduates apply new knowledge,
manage individual and aggregate
level information, and assess the
efficacy of patient care
technology appropriate to a
specialized area of practice along
with the design, selection, and use
of information systems/technology
to evaluate programs of care,
outcomes of care, and care
systems. Information
systems/technology provide a
mechanism to apply budget and
productivity tools, practice
information systems and decision
supports, and webbased learning
or intervention tools to support
and improve patient care..

7. Incorporate
ethical, regulatory,
and legal
guidelines in the
delivery of health
care and the
selection, use, and
evaluation of
information
systems and
patient care
technology.

● Built a foundation of awareness
of current laws regarding health
policy and how to become
involved through a Health Policy
course (DNPC 658, Spring
2019)
● Developed an understanding of
the basics of healthcare finance
to better understand patient,
staff, and insurance involvement
in providing adequate health
care. Gained hands-on
experience in how to create a
business plan to promote a
change to improve patient care
(DNPC 653, Summer 2019)
● Gained an understanding of
cultural humility and how to
approach diversity among our
patients through readings and
discussions in Reflective
Practice (DNPC 610, Summer
2019)
● Gained an understanding of the
different genetic tests available
to patients and the appropriate
use of these tests regarding
ethical and legal considerations
(DNPC 622, Fall 2019)
● Gained experience using an EHR
in a primary care setting to chart,
bill, send and receive patient
referrals. Also utilized resources
such as Up-to-Date and
Epocrates to deliver appropriate
and competent care to patients.
Also utilized CDC vaccine
schedule apps to guide
recommendations for patients
during primary care
appointments (NPTC 602, Fall
2019)
● Gained an understanding on how
to properly document a SOAP
note and gained hands-on
experience navigating a patient
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DNP Essential IV:
Information
Systems/Technology &
Patient Care Technology
for Improvement &
Transformation of Health
Care

7. Incorporate
ethical, regulatory,
and legal
guidelines in the
delivery of health
care and the
selection, use, and
evaluation of
NONPF:
information
Technology & Information systems and
Literacy Competencies
patient care
technology

●

●

●

●

●

chart through OSCEs in our
simulation lab (APNC 521, Fall
2019)
Created a theoretical EBP
project that utilized patient
technology services such as a
patient portal to share and collect
data with patients (DNPC 686,
Spring 2020)
Continued to use an EHR in a
primary care setting to chart,
bill, send and receive patient
referrals and utilized Up-to-Date
and Epocrates to deliver
appropriate and competent care
to patients. Also used the CDC
milestones app, USPSTF and
ASCVD apps as resources to
guide clinical practice (NPTC
604, Spring 2020)
Developed an understanding of
Telehealth practice theories
through lecture content (NPTC
605, Summer 2020) and clinical
application (NPTC 604, Spring
2020 & NPTC 605/608, Fall
2020). Also developed a
foundation for diagnostic
interpretations of x-ray imaging
(NPTC 605 & 608, Summer
2020).
Developed an understanding of
function, clinical use, and gained
hands-on application with using
lasers to treat common
dermatologic conditions (NPTC
605 & 608, Fall 2020)
Gained experience providing
ethical and compassionate care
to care to low-income and at-risk
populations including patients
with HIV, AIDS, HCV, and
substance abuse disorders at a
primary care clinical setting
(NPTC 609, Spring 2021)
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3. Demonstrate
● Built a foundation of awareness
leadership in
of Health Policy and how to
collaborative
become involved through a
efforts to develop
Health Policy course. Within this
NONPF: Policy
and implement
course submitted a policy
Competencies
policies to improve
proposal to the ANA regarding
health care
overuse of medical tests. Gained
Health care policy, whether
delivery and
awareness of current
created through governmental
outcomes at all
organizations involved in these
actions, institutional decisionlevels of
processes and how to get
making, or organizational
professional
involved (DNPC 658, Spring
standards, creates a framework
practice
2019).
that can facilitate or impede the
delivery of health care services or (institutional,
the ability of the provider to
local, state,
engage in practice to address
regional, national,
health care needs. Engagement in
the process of policy development and/or
international).
is central to creating a health
DNP Essential V: Health
Care Policy for Advocacy
in Health Care

care system that meets the needs
of its constituents. Political
activism and a commitment to
policy development are central
elements of DNP practice.

DNP Essential VI:
Interprofessional
Collaboration for
Improving Patient &
Population Health
Outcomes
NONPF: Leadership
Competencies
Today’s complex, multi-tiered
health care environment depends
on the contributions of highly
skilled and knowledgeable
individuals from multiple
professions. In order to
accomplish the IOM mandate for
safe, timely, effective, efficient,
equitable, and patient-centered
care in this environment, health
care professionals must function
as highly collaborative teams.
DNPs have advanced preparation
in the interprofessional dimension
of health care that enable them to
facilitate collaborative team

1. Demonstrate
advanced levels of
clinical practice
within defined
ethical, legal, and
regulatory
parameters in
designing,
implementing, and
evaluating
evidenced-based,
culturally
competent
therapeutic
interventions for
individuals or
aggregates.
3. Demonstrate
leadership in
collaborative
efforts to develop
and implement
policies to improve

● Built a foundation of awareness
of Health Policy and how to
become involved through a
Health Policy course (DNPC
658, Spring 2019). Within this
course submitted a policy
proposal to the ANA regarding
overuse of medical tests
● Gained experience using an EHR
in a primary care setting to send
and receive patient referrals from
other specialties within the
healthcare system. Collaborated
with other NPs and Providers
within the clinic setting to
provide competent care to
patients (NPTC 602, Fall 2019)
● Collaborated with my peers in
developing accurate physical
assessment skills in the
simulation lab (APNC 521, Fall
2019)
● Created a theoretical DNP
project that required
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functioning and overcome
impediments to interprofessional
practice. DNP graduates have
preparation in methods of
effective team leadership and are
prepared to play a central role in
establishing interprofessional
teams, participating in the work
of the team, and assuming
leadership of the team when
appropriate.

health care
delivery and
outcomes at all
levels of
professional
practice
(institutional,
local, state,
regional, national,
and/or
international).

DNP Essential VII:
Clinical Prevention &
Population Health for
Improving Nation’s
Health

6. Employ a
● Developed the ability to interpret
population health
epidemiological data and use
focus in the design,
this data to implement a primary
implementation,
prevention program for asthma
and evaluation of
in pediatric patients at public
health care
school through a project
delivery systems
completed in DNPC 625 (Fall
that address
2018)
primary,
● Developed a foundation in health
secondary, and
promotion and prevention
tertiary levels of
through lecture content on social
prevention.
determinants of health, change
theories, health disparities, and

NONPF: Leadership
Competencies
Consistent with national calls for
action and with the longstanding
focus on health promotion and
disease prevention in nursing, the
DNP graduate has a foundation

collaboration between providers,
nurses, medical assistants,
clinical managers, and patients
to improve patient understanding
and outcomes surrounding
pediatric eczema management
(DNPC 686, Spring 2020)
● Continued to utilize the EHR in
a primary care setting to send
and receive patient referrals from
other specialties within the
healthcare system. Collaborated
with other NPs and Providers
and medical assistants within the
clinic setting to provide
competent care to patients
(NPTC 604, Spring 2020)
● Became comfortable with a team
approach to treating
dermatologic conditions with
lasers at Scripps Clinic
Dermatology through hands-on
collaboration with a nurse
practitioner and LVN. Also
became comfortable with
knowing when to refer patients
to general dermatology or the
PCP for continued management
of medical conditions outside the
lasers & cosmetic dermatology
scope of practice (NPTC 605 &
608, Fall 2020)
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in clinical prevention and
population health. This
foundation enables DNP
graduates to analyze
epidemiological, biostatistical,
occupational, and environmental
data in the development,
implementation, and evaluation of
clinical prevention and
population.

6. Employ a
the differences between primary,
population health
secondary, and tertiary care.
focus in the design,
Became familiar with ACOG,
implementation,
AAP, USPSTF and their
and evaluation of
recommendations for
health care
preventative screenings and care
delivery systems
(NPTC 602, Fall 2019).
that address
● Analyzed current eczema
primary,
management within an allergy
secondary, and
clinic to determine a need for
tertiary levels of
streamlined practice regarding
prevention.
patient education to improve
patient outcomes for a mock
EBP project (DNPC 686, Spring
2020)
● Continued to develop a
foundation in health promotion
and prevention through lecture
content on bias, cross cultural
care, patient privacy, and ethical
decision making. Continued to
utilize ACOG, AAP, and
USPSTF recommendations for
preventative screenings in
primary care setting (NPTC 604,
Spring 2020).
● Perform skin checks and
treatment of actinic keratoses
with liquid nitrogen and PDT to
prevent progression of the
lesions to skin cancer at a
dermatology clinical setting.
Also provided patient education
regarding proper skin care and
protection (NPTC 605 & 608,
Fall 2020)

DNP Essential VIII:
Advanced Nursing
Practice

1. Demonstrate
advanced levels of
clinical practice
within defined
ethical, legal, and
regulatory
parameters in
designing,
implementing, and

NONPF: Independent
Practice/Ethics
Competencies The increased
knowledge and sophistication of

• Gained and understanding of
cultural humility and how to
approach diversity among our
patients through readings and
discussions in Reflective
Practice. Also practiced
reflection and mindfulness
throughout the course to learn
how to provide culturally
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health care has resulted in the
growth of specialization in
nursing in order to ensure
competence in these highly
complex areas of practice. The
reality of the growth of
specialization in nursing practice
is that no individual can master
all advanced roles and the
requisite knowledge for enacting
these roles. DNP programs
provide preparation within
distinct specialties that require
expertise, advanced knowledge,
and mastery in one area of
nursing practice. A DNP
graduate is prepared to practice
in an area of specialization within
the larger domain of nursing.

evaluating
evidence-based,
culturally
competent
therapeutic
interventions for
individuals or
aggregates.

•

•

•

•

•

•

competent and therapeutic
interventions for our patients
(DNPC 610, Summer 2019)
Gained an understanding of
when to refer patients with
complex multi-system
conditions to or when to consult
with a geneticist for a thorough
workup and management
(DNPC 622, Fall 2019)
Developed an understanding of
social determinants of health,
implicit bias, vaccine hesitancy,
billing issues, healthcare fraud,
standardized protocols, practice
authority, impact of culture, and
the role of the APRN and
clinical judgement through
lectures and class discussions
(NPTC 602, Fall 2019)
Developed physical assessment
skills for pediatric patients, adult
patients, and geriatric patients in
skills lab. These skills have
prepared me to care for patients
of all ages in any clinical setting
(APNC 521, Fall 2019)
Developed an advanced
knowledge of eczema
management in the pediatric
population through evaluation of
practices at an allergy clinic and
conduction of a literature review
for a mock EBP project (DNPC
686, Spring 2020)
Developed an advanced
knowledge and gained hands on
experience within the laser &
cosmetic dermatology
subspecialty (NPTC 605 & 608,
Fall 2020)
Gained experience with
providing ethical care to
underserved populations with
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HIV, AIDS, HCV, and STDs
using practice guidelines in a
primary care clinical setting.
Also implement levels of
primary, secondary, and tertiary
prevention when caring for these
populations using guidelines
from USPSTF and the CDC
(NPTC 609, Spring 2021)
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Patient-Oriented Eczema Measure (POEM) Form
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Parental Self-Efficacy with Eczema Care Index Form
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Eczema Action Plan
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Eczema Written Education Materials
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Caregiver Comprehension of Eczema Action Plan
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